2YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
TAE684 | NVP-TAE684 | 761439-42-3 |
CYC-116 | CYC-116 | 693228-63-6 |
N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea | N-(3-氯苯基)-N'-[5-[2-(噻吩并[3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲 | 1057249-41-8 |
Nintedanib esylate | 尼达尼布乙磺酸盐 | 656247-18-6 |
CGP60474 | 3-[[4-[2-[(3-氯苯基)氨基]-4-嘧啶基]-2-吡啶基]氨基]-1-丙醇 | 164658-13-3 |
LY2835219 | LY2835219 | 1231930-82-7 |
AA41612 | 化合物AA41612 | 433690-62-1 |
FITM | 4-氟-N-[4-[6-(异丙基氨基)嘧啶-4-基]-1,3-噻唑-2-基]-N-甲基苯甲酰胺 | 932737-65-0 |
CP 94253 dihydrochloride | CP 94253盐酸盐 | 845861-39-4 |
NI-57 | NI-57 | 1883548-89-7 |
Dovitinib | 4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮 | 405169-16-6 |
Indibulin | 2-(1-(4-氯苄基)-1H-吲哚-3-基)-2-氧代-N-(吡啶-4-基)乙酰胺 | 204205-90-3 |
Ibrutinib | 依鲁替尼 Ibrutinib(PCI-32765) | 936563-96-1 |
Carfilzomib | 卡非佐米 | 868540-17-4 |
Varlitinib | 泛EGFR小分子抑制剂(VARLITINIB) | 845272-21-1 |
LDC000067 | (3-(6-(2-甲氧基苯基)嘧啶-4-基氨基)苯基)甲烷磺酰胺 | 1073485-20-7 |
BMS 986187 | BMS 986187 | 684238-37-7 |
3,5-Bis[(4-nitrophenyl)methylene]-2,3,5,6-tetrahydro-4H-thiopyran-4-one-1,1-dioxide;3,5-bis((4-Nitrophenyl)methylene)-1,1-dioxide;tetrahydro-4H-thiopyran-4-one;NSC-144303;Ubiquitin Isopeptidase Inhibitor I;tetrahydro-3,5-bis[(4-nitrophenyl)methylene]-4H-t | 108477-18-5 | 108477-18-5 |
Src Inhibitor-1 | 7-二甲氧基-N-(4-苯氧基苯基)- 氨基喹唑啉 | 179248-59-0 |
GSK 2018682 | CPD1224 | 1034688-30-6 |
Sapitinib | AZD8931 | 848942-61-0 |
Necrosulfonamide | N-[4-[[(3-甲氧基吡嗪基)氨基]磺酰基]苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺 | 432531-71-0 |
Afatinib dimaleate | 双马来酸盐阿法替尼 | 850140-73-7 |
K-Ras(G12C) inhibitor 12 | K-RAS(G12C) INHIBITOR 12 | 1469337-95-8 |
Pexidartinib | 培西达替尼 | 1029044-16-3 |
ML 179 | ML-179 | 1883548-87-5 |
2-undecyl-thiazolidine-4-carboxylic acid | 2-UNDECYL-THIAZOLIDINE-4-CARBOXYLIC ACID | 298186-80-8 |
MYCi361 | MYCI361 | 2289690-31-7 |
TSU-68 | orantinib | 252916-29-3 |
RS 67333 hydrochloride | RS 67333盐酸盐 | 168986-60-5 |
Trametinib | 曲美替尼 | 871700-17-3 |
Fostamatinib Disodium | R788(FOSTAMATINIB DISODIUM) | 1025687-58-4 |
BIBO3304 TFA | N-[(1R)-1-[[[[4-[[(Aminocarbonyl)amino]methyl]phenyl]methyl]amino]carbonyl]-4-[(aminoiminomethyl)amino]butyl]-α-phenyl-benzeneacetamideditrifluoroacetate | 191868-14-1 |
EGFR inhibitor | EGFR INHIBITOR | 879127-07-8 |
BMS-265246 | BMS265246 | 582315-72-8 |
Osilodrostat | LCI 699 | 928134-65-0 |
MG-132 | MG132,蛋白酶体抑制剂 | 133407-82-6 |
TCS-OX2-29 | TCS-OX2-29 HCl | 1610882-30-8 |
PF 05190457 | PF-05190457, CID 58438464 | 1334782-79-4 |
CGS 15943 | CGS 15943 | 104615-18-1 |
Selpercatinib | 塞卡替尼 | 2152628-33-4 |
Lopinavir | 洛匹那韦 | 192725-17-0 |
Cediranib | 西地尼布 | 288383-20-0 |
Telaprevir | 特拉匹韦(VX-950) | 402957-28-2 |
Aurora kinase inhibitor-3 | AURORA KINASE INHIBITOR III | 879127-16-9 |
Motolimod | MOTOLIMOD | 926927-61-9 |
GC376 | GC376 | 1416992-39-6 |
CAY10404 | 3-(4-METHYLSULPHONYLPHENYL)-4-PHENYL-5-TRIFLUOROMETHYLISOXAZOLE | 340267-36-9 |
OSI-420 | 2-[[4-[(3-乙炔基苯基)氨基]-7-(2-甲氧基乙氧基)-6-喹唑啉基]氧基]乙醇 | 183321-86-0 |
Trandolaprilat | 群多普利 | 87679-71-8 |
Linifanib | 利尼伐尼 | 796967-16-3 |
Thiamet G | THIAMET G | 1009816-48-1 |
R788 | 福他替尼 | 901119-35-5 |
TCS 1102 | TCS 1102 | 916141-36-1 |
4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrate | 瑞格非尼一水合物 | 1019206-88-2 |
Dovitinib (TKI-258) Dilactic Acid | 多韦替尼二乳酸 | 852433-84-2 |
K-115 | (2S)-1-[(4-氟-5-异喹啉基)磺酰基]六氢-2-甲基-1H-1,4-二氮杂卓单盐酸盐二水合物 | 887375-67-9 |
GNE-0877 | GNE-0877 | 1374828-69-9 |
Pemigatinib | 培米加替尼 | 1513857-77-6 |
BVT 948 | 4-羟基-3,3-二甲基-2H-苯并[G]吲哚-2,5(3H)-二酮 | 39674-97-0 |
Raltegravir | 雷特格韦 | 518048-05-0 |
AH 6809 | 6-异丙氧基-9-氧代氧杂蒽-2-羧酸 | 33458-93-4 |
GSK461364 | GSK461364 | 929095-18-1 |
Alectinib | 艾乐替尼 | 1256580-46-7 |
MK-5108 (VX-689) | MK-5108 (VX-689) | 1010085-13-8 |
ASP-3026 | ASP3026 | 1097917-15-1 |
PRX 07034 | 5-氯-2,3-二甲氧基-Α-甲基-N-[2-(甲基磺酰基)-5-(1-哌嗪基)苯基]-苯甲胺盐酸盐 | 903580-39-2 |
GSK-J4 | N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯 | 1373423-53-0 |
CYM 5520 | 1-[2-(1-Benzyl-2,5-dimethyl-1H-pyrrol-3-yl)-2-oxo-ethyl]-6-oxo-1,6-dihydro-pyridine-3-carbonitrile | 1449747-00-5 |
Derazantinib | 德拉赞替尼 | 1234356-69-4 |
Favipiravir | 法匹拉韦 | 259793-96-9 |
Ki8751 | Ki8751 | 228559-41-9 |
PF-562271 | N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺 | 717907-75-0 |
Nintedanib | 尼达尼布 | 656247-17-5 |
Rhosin hydrochloride | 1281870-42-5 | 1281870-42-5 |
SHA 68 | SHA 68 | 847553-89-3 |
PHCCC | N-苯基-7-(羟基亚胺基)环丙烯并[B]苯并吡喃-1A-甲酰胺 | 179068-02-1 |
Tropifexor | Tropifexor | 1383816-29-2 |
Flavopiridol | 2-(2-氯苯基)-5,7-二羟基-8-[(3S,4R)-3-羟基-1-甲基-4-哌啶基]苯并吡喃-4-酮 | 146426-40-6 |
UC2288 | 1394011-91-6 | 1394011-91-6 |
GSK-3 Inhibitor XIII | (5-METHYL-1H-PYRAZOL-3-YL)-(2-PHENYLQUINAZOLIN-4-YL)AMINE | 404828-08-6 |
LE 135 | LE 135 | 155877-83-1 |
EC-23 | 4-[2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)ethynyl)-benzoicacid | 104561-41-3 |
AMG 900 | AMG 900 | 945595-80-2 |
CUDA | CUDA | 479413-68-8 |
Osimertinib mesylate | AZD9291(甲磺酸盐) | 1421373-66-1 |
Gilteritinib | 吉列替尼 | 1254053-43-4 |
MPP dihydrochloride | MPP 二盐酸盐 | 911295-24-4 |
ZM-447439 | ZM 447439 | 331771-20-1 |
L-371257 | L371,257 | 162042-44-6 |
DCPIB | DCPIB | 82749-70-0 |
KU57788(NU7441) | 8-(4-二苯并噻吩基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮 | 503468-95-9 |
Sorafenib | 索拉非尼 | 284461-73-0 |
AZD-4547 | AZD-4547 | 1035270-39-3 |
Letermovir | 莱特莫韦 | 917389-32-3 |
LY2801653 | 梅沙替尼 | 1206799-15-6 |
(±)-Marinopyrrole A | (±)-MARINOPYRROLE A | 1227962-62-0 |
CCT196969 | CB93134226 | 1163719-56-9 |
LYN-1604 | 蓝木定制的新产品 | 2088939-99-3 |
GsMTx4 TFA | GSMTX4 TFA |
联系方式